Table 1.

Laboratory data on admission.

	Value	Ref.
Blood
Glucose, mg/dL	1194	70–100
Urea, mg/dL	96	19–43
Creatinine, mg/dL	2.4	0.66–1.25
eGFR (MDRD; mL/min/1.73 m2)	28	>60
Na, mmol/L	117	137–145
K, mmol/L	5.6	3.4–5.0
Cl, mmol/L	86	98–107
HCO3, mmol/L	6	22–30
Anion Gap, mmol/L	31	10–18
Ca, mmol/L	1.86	2.10–2.50
P, mmol/L	0.77	0.81–1.45
Mg, mmol/L	0.95	0.66–0.95
Alb, g/L	31	35–50
CRP, mg/L	100.3	<5
LDH, U/L	408	313–618
AST, U/L	16	17–59
ALT, U/L	29	21–72
ALP, U/L	113	38–126
GGT, U/L	36	<73
Bili, mg/dL	0.43	0.2–1.3
Lipase, U/L	970	23–300
Platelet, ×103/mm3	305	158–450
Hb, g/dL	14.3	13.0–16.5
WBC, ×103/mm3	21.9	3.6–9.6
Neutrophils, %	86.0	41.0–74.0
(Absolute), ×103/mm3	18.834	1.4–6.7
Urine
Protein	Negative
Glucose, g/L	++++
	44.3
Creatinine, mg/dL	25
Na, mmol/L	10
Osm, mosmol/kg H2O	418
Arterial blood gas
pH	6.944	7.35–7.45
PaCO2, mmHg	18.5	36–44
PaO2, mmHg	86.5	65–80
HCO3, mmol/L	4.0	22–26
Base excess, mmol/L	−26.2	−2, +2
Lactate, mmol/L	1.6	0.7–2.1
Thyroid (before the start of immunotherapy)
TSH, mIU/L	1.11	0.27–4.2
fT4, pmol/L	12.4	11.0–24.0
Diabetes
ICA	Negative
Insulin Ab, % binding	0.5	<0.6
GADA, WHO U/mL	>171	<23
IA2A, WHO U/mL	<0.1	<1.4
C-peptide, nmol/L	0.02	0.29–0.99